African Research Institutions Launch Phase 1 HIV Vaccine Clinical Trial in Southern Africa
8 August 2025 – Harare, Zimbabwe / Cape Town & Durban, South Africa – African clinical research institutions, in partnership with global collaborators, have launched a Phase 1 clinical trial to evaluate a novel HIV vaccine candidate, GRAdHIVNE1. The trial is being...A Milestone in HIV Prevention Research: First Doses Administered at Mutala Trust
Harare, Zimbabwe; Rome, Italy; New York, NY, and Cambridge, MA, USA — August 4, 2025 — The Mutala Trust, ReiThera Srl (ReiThera), the Ragon Institute of Mass General Brigham, MIT, and Harvard (the Ragon Institute), and IAVI are pleased to announce that the first doses...
Reflections from our CEO at the DIA2025 Conference
DIA (Drug Information Association) brings together global leaders from across the life sciences to advance innovation in health — from regulatory science to drug development to patient-centered care. It’s where science, policy, and people intersect. This year, what...
Why Influenza Surveillance Matters for Africa
Influenza is a serious but often underestimated public health threat in Africa. The continent faces a triple challenge: under-recognition of disease burden, insufficient surveillance, and limited capacity to detect and respond to seasonal or pandemic influenza...
e-Newsletter – April and May 2025
External e-newsletter 2nd edition 30 May 2025 April & May in Review The past two months have been a period of vibrant activity for ACRN. From high-level engagements and regional travel to hosting key partners and sharing our vision on global...
ACRN ‘s Inspirational Story at the Gates 25th Anniversary Celebration
Earlier this month, ACRN CEO Dr. Tariro Makadzange joined notable figures, including Bill Gates and Mark Suzman, at Carnegie Hall in New York to celebrate the 25th Anniversary of the Gates Foundation. The event featured a keynote address by Bill Gates, who...
Building a Healthier Future through science and education
We were honored to host the Higherlife Foundation team at the Infectious Diseases Research Laboratory (IDRL) in Zimbabwe. Their visit highlighted the shared commitment to advancing health innovation and scientific research in Africa. From strengthening diagnostic...
Africa at the Frontier of Genomic Research: A Landmark Genome-Wide Association Study Reinforces the Imperative for African-Led Clinical Trials
Breast cancer is rising across Africa, yet most genomic insights that guide diagnostics and treatment still originate from non-African populations. The recent Hayat et al. (2025) genome-wide association study (GWAS)—the first conducted exclusively in a resident Black...